Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-25T05:02:56.353Z Has data issue: false hasContentIssue false

LO45: Incidence of delayed intracranial hemorrhage following a mild traumatic brain injury in patients taking anticoagulants or anti-platelets therapies: systematic review and meta-analysis

Published online by Cambridge University Press:  11 May 2018

M. Emond*
Affiliation:
Université Laval, Québec, PQ
A. Laguë
Affiliation:
Université Laval, Québec, PQ
T. O’Brien
Affiliation:
Université Laval, Québec, PQ
B. Mitra
Affiliation:
Université Laval, Québec, PQ
P. Tardif
Affiliation:
Université Laval, Québec, PQ
N. Le Sage
Affiliation:
Université Laval, Québec, PQ
M. D Astous
Affiliation:
Université Laval, Québec, PQ
E. Mercier
Affiliation:
Université Laval, Québec, PQ
*
*Corresponding author

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Introduction: Head injury is a common presentation to all emergency departments. Previous research has shown that such injuries may be complicated by delayed intracranial hemorrhage (D-ICH) after the initial scan is negative. Exposure to anticoagulant or anti-platelet medications (ACAP) may be a risk factor for D-ICH. We have conducted a systematic review and meta-analysis to determine the incidence of delayed traumatic intracranial hemorrhage in patients taking anticoagulants, anti-platelets or both. Methods: The literature search was conducted in March 2017 with an update in April 2017. Keyword and MeSH terms were used to search OVID Medline, Embase and the Cochrane database as well as grey literature sources. All cohort and experimental studies were eligible for selection. Inclusion criteria included pre-injury exposure to oral anticoagulant and / or anti-platelet medication and a negative initial CT scan of the brain (CT1). The primary outcome was delayed intracranial hemorrhage present on repeat CT scan (CT2) within 48 hours of the presentation. Only patients who were rescanned or observed minimally were included. Clinically significant D-ICH were those that required neurosurgery, caused death or necessitated a change in management strategy, such as admission. Results: Fifteen primary studies were ultimately identified, comprising a total of 3801 patients. Of this number, 2111 had a control CT scan. 39 cases of D-ICH were identified, with the incidence of D-ICH calculated to be 1.31% (95% CI [0.56, 2.27]). No more than 12 of these patients had a clinically significant D-ICH representing 0.09% (95% CI [0.00, 0.31]). 10 of them were on warfarin and two on aspirin. There were three deaths recorded and three patients needed neurosurgery. Conclusion: The relatively low incidence suggests that repeat CT should not be mandatory for patients without ICH on first CT. This is further supported by the negligibly low rate of clinically significant D-ICH. Evidence-based assessments should be utilised to indicate the appropriate discharge plan, with further research required to guide the balance between clinical observation and repeat CT.

Type
Oral Presentations
Copyright
Copyright © Canadian Association of Emergency Physicians 2018